Menu
Home
Publishers
Categories
Trending
Inbox
Create Account
Sign in
Nederlands
Deutsch
Loading...
Fiercebiotech.com
Click on 'Go to the website!' to go to Fiercebiotech.com.
Button get active in
5
Continue to the website!
Loading...
Loading...
Other newsletters from Fiercebiotech.com
| 12.04.24 | AZ, Roche and others score in China drug reimbursement talks; Genmab bets up to $630M on Scancell antibody
Fiercebiotech.com
1733345506
| 12.04.24 | GSK inks pair of pipeline deals, axes hep B trial; Novo Holdings-backed Antag raises $84M for GLP-1 add-on
Fiercebiotech.com
1733334418
AI Podcast: Transforming the Biopharmaceutical Industry
Fiercebiotech.com
1733318778
E, Are you joining us?
Fiercebiotech.com
1733318323
| 12.03.24 | Genetics biotech Maze picks up $115M series D; Healthcare topics to watch under Trump 2.0
Fiercebiotech.com
1733258807
| 12.03.24 | Biobucks fly as Roche, Gilead, BMS, Take da & more ink deals; Roivant’s ph. 2 lung trial flops
Fiercebiotech.com
1733247131
| 12.02.24 | Novartis scoops up $1B Huntington’s as set; Sanofi reveals largest China investment to date
Fiercebiotech.com
1733171582
| 12.02.24 | Novartis forks over $1B for PTC's Huntington's asset; FDA rejects rare disease drug after ph. 3 fail
Fiercebiotech.com
1733161870
Transform Your Drug Research in Minutes
Fiercebiotech.com
1733154149
Novel Cell Lysis Solution: Scaling up the harvest process while preserving what matters
Fiercebiotech.com
1733153749
| 11.27.24 | Novartis plots field sales layoffs linked to Xolair, cancer combo; Trump picks Stanford economist to helm NIH
Fiercebiotech.com
1732735608
| 11.27.24 | Trump names NIH pick; PTC axes ALS program, gains $150M in voucher sale
Fiercebiotech.com
1732727425
| 11.26.24 | Amgen’s obesity data disappoint investo rs; Guardant awarded $292M in false advertising suit
Fiercebiotech.com
1732653996
Final Opportunity: Join honorees from Microsoft Research, NRHA, GARDP and more at the Fierce 50 Gala
Fiercebiotech.com
1732653403
| 11.26.24 | Amgen’s ph. 2 obesity data disappoint inv estors; Roche buys Poseida for $1.5B while TIGIT flops
Fiercebiotech.com
1732641243
The Future of Oncology Unveiled
Fiercebiotech.com
1732632527
| 11.25.24 | Pfizer leads Big Pharma's Q3 sales sur ge; Cassava ends Alzheimer’s trial after ph. 3 flop
Fiercebiotech.com
1732568817
| 11.25.24 | Cassava ends Alzheimer’s trial after ph .3 flop; Biohaven plots obesity pivot after SMA fail
Fiercebiotech.com
1732552737
Optimizing Your Patient Support Strategy with Hub Model Innovation
Fiercebiotech.com
1732547711
| 11.23.24 | House passes sweeping nonprofits bill; Trump taps Dr. Oz to run CMS
Fiercebiotech.com
1732368755
© 2024
Information
Terms and Conditions
Privacy
Close
Home
Publishers
Categories
Trending
Inbox
Create Account
Sign in
© 2024
Information
Terms and Conditions
Privacy
Nederlands
Deutsch